In this guide
What is Spirulina?
Products called spirulina usually contain dried Arthrospira platensis or A. maxima, cyanobacteria rather than true algae. Species, cultivation water, harvest, drying, microbial control and finished-product testing affect composition. [1], [3], [5]
Typical Spirulina Protocols
| Source and question | Preparation | Amount each administration | Daily total | Frequency and duration | Main interpretation |
|---|---|---|---|---|---|
| Rahnama 2023 · lipid meta-analysis · 20 studies/1,076 participants | Spirulina products versus controls | Varied | Varied | Durations varied | Total cholesterol, LDL, triglycerides and HDL favored spirulina; formulations and populations varied |
| Nourollahian 2020 · rhinitis RCT · 65 enrolled; 53 assigned in report | Spirulina versus cetirizine 10 mg/day | 2 g across four capsules | 2 g/day | Four capsules daily for 2 months | One spirulina participant later declined continuation; single-blind active-comparator study without placebo |
| Sochacka 2025 · 52-product analytical study | 29 conventional and 23 organic products | Not an administration study | Not applicable | One analytical sampling program | Metals met applied limits; pharmaceutical residues and aluminum-intake concern remained |
- Exact product
- Record species, form, lot and co-ingredients.
- Each administration
- Keep amount, timing and context.
- Real endpoint
- Separate biomarker, symptom and clinical outcome.
What is it commonly used for?
A 2023 GRADE-assessed meta-analysis pooled 20 randomized studies, 23 arms and 1,076 participants and reported lipid signals, but products, doses and populations varied. A single-blind rhinitis trial enrolled 65 patients, reported 53 assigned to spirulina or cetirizine, and then excluded one spirulina participant who declined to continue. Four capsules supplied 2 g spirulina daily for two months. Selected symptoms favored spirulina, without placebo, participant blinding, long follow-up or replication. [1], [2], [1], [2]
One result answers one question
How do forms and labels differ?
Record Arthrospira species, powder or tablet, serving mass, protein and micronutrient assay, lot-specific microcystin and microbial testing, and third-party certificate date. Blue-green color is not proof of identity or purity. [4], [3], [4]
How should the product be stored?
Follow the finished product’s label, keep it dry in its original container and away from children. Discard an expired, heat-damaged, broken-seal or untraceable product.
What does human research show?
| Question | Best direct evidence | Finding | Boundary |
|---|---|---|---|
| Efficacy | Rahnama 2023 · lipid meta-analysis · 20 studies/1,076 participants | Total cholesterol, LDL, triglycerides and HDL favored spirulina; formulations and populations varied | Specific product and population |
| Replication | Limited evidence | No universal effect established | Variable formulations |
| Universal dose? | None | Not established | Rows cannot be combined |
Keep the finished product reviewable
What are the risks and interactions?
Contaminated cyanobacterial products can expose users to microcystins or unwanted microbes. Gastrointestinal symptoms and allergy are possible. Phenylketonuria, autoimmune disease, immunosuppressants, pregnancy, breastfeeding and liver disease warrant review. Do not use spirulina to treat toxic exposure. [2], [3], [5], [3], [4], [5]
Seek urgent care for severe vomiting, jaundice, confusion, breathing difficulty, widespread hives or suspected contaminated-product poisoning. Report the exact product and lot.
What is the legal and regulatory status?
In the United States, it is sold as a dietary supplement; FDA does not approve it for safety and effectiveness before sale. In Canada, verify the exact product, NPN and authorized label. Legal sale does not prove efficacy or sport suitability. [6]
When should use stop?
Stop for any allergic reaction, persistent symptom worsening, unexpected laboratory result or doubt about product identity.
What should be monitored?
Keep lot, certificate, administrations, symptoms and the intended nutrition outcome together. Stop for a quality alert or unexplained liver, allergic or gastrointestinal symptoms. Protein intake and a disease endpoint are different questions.
What can community experience add?
Reports can compare taste, mixing and tolerance. They cannot detect cyanotoxins, microbes or pharmaceutical residues. No systematic current community sample was assembled.
How do related options compare?
| Option | Main distinction |
|---|---|
| Arthrospira powder | Bulk product; lot testing needed |
| Tablets | Same quality questions plus excipients |
| Chlorella | Distinct green microalga with different cell wall and evidence |
Common questions
Is spirulina an algae?
Commercial spirulina is usually Arthrospira, a cyanobacterium.
Does every product contain cyanotoxins?
No; sampling studies show a risk requiring lot controls, not universal contamination.
Does organic status prove purity?
No.
Can it detox heavy metals?
No validated chelation role is established.
What testing matters?
Lot-specific identity, microcystins, microbes and relevant contaminants.
What should be monitored?
Exact lot, intake, symptoms and the defined nutrition endpoint.
Glossary
Terms for reading the evidence.
- Endpoint
- A defined result measured in a study.
- Anaphylaxis
- A potentially life-threatening systemic allergic reaction.
- Biomarker
- A biological measure that does not guarantee clinical benefit.
- Standardization
- A measured specification for a product component.
- Cross-reactivity
- Immune recognition of related proteins from different sources.
How this guide was researched
NCBI identities, publication notices, indexed abstracts and available open methods were checked. Null outcomes, mixed products, surrogate endpoints and missing details remain visible.
Research record · checked October 9, 2026
Identity: EFetch verified PMIDs 37263369 and 32773785; PMC10221061 was verified as PMID 37317149. No linked correction or retraction appeared.
Methods: PMC7416373 confirmed 53 analyzed, four capsules totaling 2 g/day, active comparator and single-blind design.
Boundary: efficacy and product-quality studies answer different questions; sampled findings are not universal prevalence.
Explore the sources
Primary human evidence and official context.
Showing 6 sources
- 01
The effect of Spirulina supplementation on lipid profile: GRADE-assessed systematic review and dose-response meta-analysis of data from randomized controlled trials. ↗
GRADE-assessed systematic review and meta-analysis
Twenty studies, 23 arms and 1,076 participants; pooled lipid markers favored spirulina, while products, doses and populations varied.
- 02
Clinical comparison of the efficacy of spirulina platensis and cetirizine for treatment of allergic rhinitis. ↗
Randomized single-blind active-comparator trial
Sixty-five enrolled; the report says 53 were assigned, then one spirulina participant declined continuation. Four capsules supplied 2 g/day for two months versus cetirizine 10 mg/day.
- 03
Microbiota and Cyanotoxin Content of Retail Spirulina Supplements and Spirulina Supplemented Foods. ↗
Retail microbiology and cyanotoxin study
Sampled products contained diverse microbes and cyanotoxins; the study assessed products, not clinical outcomes or every market lot.
- 04
Spirulina and Chlorella Dietary Supplements-Are They a Source Solely of Valuable Nutrients? ↗
Analytical study of 52 products
Metals were within the applied EU limits, while pharmaceutical residues and an aluminum-intake concern were reported.
- 05
Spirulina ↗
Official lactation evidence review
Human lactation data are limited; product contamination and variable composition remain relevant.
- 06
FDA 101: Dietary Supplements ↗
Official supplement overview
FDA does not approve dietary supplements for safety and effectiveness before sale.
No matching sources
Try a different term or show the full list.
Editorial note
This guide separates composition, biomarker, symptom and clinical outcome. It does not turn a narrow signal into a general promise.